Drug intelligence / Profile preview

Ganmiao Kangning granules

Development stage
Unknown
Lead developer
Beijing Beiyi Modern Traditional Chinese Medicine Technology Development Center
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ganmiao Kangning granules is a traditional Chinese medicine (TCM) candidate developed by the Beijing Beiyi Modern Traditional Chinese Medicine Technology Development Center for the treatment of the common cold, specifically the wind-heat pattern. It is a botanical formulation designed to alleviate symptoms such as fever, sore throat, and nasal congestion. The drug underwent a randomized, double-blind, placebo-controlled Phase 2 clinical trial in China to evaluate its safety and efficacy across different dosage levels in adult patients. As a granule formulation, it is intended for oral administration and follows traditional principles of clearing heat and expelling wind.

Other names
Ganmiao Kangning Keli感冒康宁颗粒

Beyond the preview

Go deeper on Ganmiao Kangning granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganmiao Kangning granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call